expensive, and suitable for performing replicate determinations easily. In view of these advantages, this method was used to characterize more fully the stability of yellow fever virus in aerosols.
This report describes the aerosol stability of yellow fever virus at different combinations of temperature [30, 50, and 80 F (-1.11, 10, and 26.67 C)] and relative humidity (30, 50, and 80%).
MATERIALS AND METHODS
Virus. A plasma suspension of the Asibi strain of yellow fever virus was used throughout this study. Infective plasma was obtained from rhesus monkeys that had been inoculated intraperitoneally with 6 X 106 cell-infecting units (CIU) of virus and bled at the peak of the febrile response. The plasma was divided into 4.5-ml portions, sealed in glass vials, and stored at -60 C. The plasma suspension of virus had a titer of approximately 1.2 X 108 CIU per ml.
Aerobiological procedures. Aerosol tests with the virus were carried out in an insulated, cylindrical chamber with a volume of 4,800 liters. The design and construction of the chamber was similar to that described by Wolfe (8) . Humidity of the chamber atmosphere was controlled by varying the moisture content of the secondary air supply with driers or by injection of small amounts of water. Relative humidity (RH) was measured directly in the chamber by sensing elements (Hydristor, Electrical Hygrometer Element, Bendix Aviation Corp., Baltimore, Md.). The temperature of the chamber atmosphere was measured by a Foxboro recorder (Foxboro Co., Foxboro, Mass.) and controlled by a jacket containing circulating ethylene glycol.
The preparation to be atomized consisted of a mixture of 4.0 ml of virus suspension and 1 ml of a solution of uranine (the disodium salt of fluorescein) incorporated as a physical tracer. The final concentration of the tracer in the suspension was 0.5 mg per ml; preliminary tests had indicated that as much as 1 mg per ml was not detrimental to virus viability. In each aerosol test, the virus-tracer mixture was atomized completely within 20 sec by 50 lb/in2 of nitrogen through the FK-8 atomizer. At designated intervals after dissemination, the concentration of the cloud was determined by sampling for 1 min with AGI-30 all-glass impingers (Ace Glassware Co., Vineland, N.J.). The flow rates of impingers ranged from 11.4 to 12.6 liters per min. A 20-ml amount of impinger fluid, consisting of medium 199 with 5% calf serum and 2 to 3 drops of sterile olive oil as an antifoamite, was used to sample the cloud for virus. Simultaneously with biological sampling, impingers containing distilled water were used to sample the cloud for physical tracer.
Representative samples of aerosols were collected in settling jars for particle size determination (W. C. Day, unpublished data). The size-frequency distribution of particles was determined microscopically by visual sizing with the use of a Porton graticule (4) . In this report, the size of particles is described as a volume median diameter (VMD), which is that particle size above and below which 50% of the total volume of particles are found. It was derived by plotting the cumulated percentages of particles against diameters. The VMD of the aerosol particles was the diameter at the point where the line inter-cepted the 50% axis. Analysis. The basic data reported were the total number of CIU sprayed, the number of CIU recovered per milliliter of impinger fluid, the milligrams of fluorescein dye sprayed, and the milligrams of fluorescein recovered per ml of impinger fluid. Percentages of recoveries were computed as follows:
Percentage of viable recovery = (CIU/ml) (impinger volume)/(impinger flow rate in liters per min) X (chamber volume)/(CIU sprayed) X 100.
Percentage of physical recovery = (mg/ml) (impinger volume)/(impinger flow rate in liters per min) X (chamber volume)/(mg sprayed) X 100.
Percentage of biological recovery = viable rerecovery/physical recovery X 100. From 
